DOMPE' FARM S P A has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and packaging and shipping are NOVARTIS PHARMACEUTICALS CORP, BERINGER INGEL GEJM KG and VERRICA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Republic of Korea | 4 | |
#3 | Canada | 3 | |
#4 | Singapore | 2 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Packaging and shipping | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering | |
#6 | Machine tools | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Gentile Marco Maria | 8 |
#2 | Bianchini Gianluca | 6 |
#3 | Brandolini Laura | 5 |
#4 | Aramini Andrea | 5 |
#5 | Allegretti Marcello | 4 |
#6 | Lillini Samuele | 3 |
#7 | Cesta Maria Candida | 2 |
#8 | Nano Giuseppe | 2 |
#9 | Angelico Patrizia | 2 |
#10 | Beccari Andrea | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017108632A1 | 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists | |
KR20170031664A | 2-aryl-4-hydroxy-1,3-thiazole derivatives useful as trpm8-inhibitors in treatment of neuralgia, pain, copd and asthma |